While investigating the role of calcium pumps and proteins in breast cancer calcium signaling, Pera et al. observed that a high level of CaV3.2 expression in luminal type ER-positive breast cancer co-occurred with an increased level of ESR1 in patient samples from the TCGA (The Cancer Genome Atlas) database [186]. The gene discussed is ESR1; the disease is breast cancer.